Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Dec 20, 2024, 4:00 PM
1.850
+0.070 (3.93%)
After-hours: Dec 20, 2024, 6:37 PM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $78.32 million as of December 20, 2024. Its market cap has increased by 82.70% in one year.
Market Cap
78.32M
Enterprise Value
45.93M
1-Year Change
82.70%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $78.32M, a decrease of -90.85%. That is a compound annual growth rate of -34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 78.32M | 74.00% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | 819.45M | -45.64% |
| Dec 31, 2019 | 1.51B | 76.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 78.06M |
| InspireMD | 77.73M |
| Ikena Oncology | 77.70M |
| I-Mab | 77.69M |
| PMV Pharmaceuticals | 77.62M |
| Theratechnologies | 76.87M |
| Genelux | 74.69M |
| Rani Therapeutics Holdings | 74.66M |